| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.00093 | 1 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.00063 | 1 |